Mechanism-based cancer prevention approaches: Targets, examples, and the use of transgenic mice

被引:123
作者
Hursting, SD
Slaga, TJ
Fischer, SM
DiGiovanni, J
Phang, JM
机构
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Epidemiol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Cancer Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA
[3] AMC Canc Res Ctr, Ctr Canc Causat & Prevent, Denver, CO USA
[4] NCI, Lab Nutr & Mol Regulat, Frederick Canc Res & Dev Ctr, Frederick, MD USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1999年 / 91卷 / 03期
关键词
D O I
10.1093/jnci/91.3.215
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Humans are exposed to a wide variety of carcinogenic insults, including endogenous and man-made chemicals, radiation, physical agents, and viruses. The ultimate goal of carcin genesis research is to elucidate the processes involved in the induction of human cancer so that interventions may be developed to prevent the disease, either in the general population or in susceptible subpopulations. Progress to date in the carcinogenesis field, particularly regarding the mechanisms of chemically induced cancer, has revealed several points along the carcinogenesis pathway that may be amenable to mechanism-based prevention strategies. The purpose of this review is to examine the basic mechanisms and stages of chemical carcinogenesis, with an emphasis on ways in which preventive interventions can modify those processes. Possible ways of interfering with tumor initiation events include the following: i) modifying carcinogen activation by inhibiting enzymes responsible for that activation or by direct scavenging of DNA-reactive electrophiles and free radicals; ii) enhancing carcinogen detoxification processes by altering the activity of the detoxifying enzymes; and iii) modulating certain DNA repair processes. Possible ways of blocking the processes involved in the promotion and progression stages of carcinogenesis include the following: i) scavenging of reactive oxygen species; ii) altering the expression of genes involved in cell signaling, particularly those regulating cell proliferation, apoptosis, and differentiation; and iii) decreasing inflammation. In addition, the utility for mechanism-based cancer prevention research of new animal models that are based on the overexpression or inactivation of specific cancer-related genes is examined.
引用
收藏
页码:215 / 225
页数:11
相关论文
共 116 条
[1]   Transgenic and knock-out models for studying DNA repair [J].
Allemand, I ;
Angulo, JF .
BIOCHIMIE, 1995, 77 (10) :826-832
[2]   OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[3]   Sulindac suppresses tumorigenesis in the Min mouse [J].
BeazerBarclay, Y ;
Levy, DB ;
Moser, AR ;
Dove, WF ;
Hamilton, SR ;
Vogelstein, B ;
Kinzler, KW .
CARCINOGENESIS, 1996, 17 (08) :1757-1760
[4]   THE EFFECT OF PSORALENS ON HEPATIC AND CUTANEOUS DRUG-METABOLIZING-ENZYMES AND CYTOCHROME-P-450 [J].
BICKERS, DR ;
MUKHTAR, H ;
MOLICA, SJ ;
PATHAK, MA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 79 (03) :201-205
[5]  
BIRT DF, 1989, CANCER RES, V49, P4170
[6]   ENHANCEMENT OF BOP-INDUCED PANCREATIC CARCINOGENESIS IN SELENIUM-FED SYRIAN GOLDEN-HAMSTERS UNDER SPECIFIC DIETARY CONDITIONS [J].
BIRT, DF ;
JULIUS, AD ;
RUNICE, CE ;
WHITE, LT ;
LAWSON, T ;
POUR, PM .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1988, 11 (01) :21-33
[7]  
BIRT DF, 1995, SKIN CANC MECH HUMAN, P371
[8]  
BLUMBERG PM, 1988, CANCER RES, V48, P1
[9]  
Boolbol SK, 1996, CANCER RES, V56, P2556
[10]   MODULATION OF RAT HEPATIC-MICROSOMAL MONOOXYGENASE ENZYMES AND CYTOTOXICITY BY DIALLYL SULFIDE [J].
BRADY, JF ;
WANG, MH ;
HONG, JY ;
XIAO, F ;
LI, Y ;
YOO, JSH ;
NING, SM ;
LEE, MJ ;
FUKUTO, JM ;
GAPAC, JM ;
YANG, CS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (02) :342-354